AliveX Biotech Achieves ISO9001:2015 Certification, Reinforcing Global Quality Standards Ahead of IPO Filing
AliveX Biotech
Precision Medicine Solution Provider
Recently, AliveX Biotech in Shanghai successfully passed the ISO9001 Quality Management System certification and was awarded an internationally authoritative certification.This certification marks that AliveX Biotech meets international advanced standards in quality management and service level, and can continuously deliver high-quality results for customers in the global life science field.
ISO9001:2015 Quality Management System Certification
AliveX Biotech is committed to providing customers with stable, reliable, and continuously optimized solutions.The recent ISO9001 certification not only represents high recognition of AliveX Biotech's quality management and service level but also demonstrates the company's relentless pursuit and commitment to continuous improvement and high-standard service.
About ISO9001 Certification
ISO9001 was developed by the International Organization for Standardization (ISO).More than one million organizations across over 180 countries and regions worldwide are using this framework, which is an internationally recognized quality management standard and a globally authoritative certification for corporate quality management. This certification covers all aspects of quality management, including the company's quality policy, the establishment of quality objectives, resource management, process control, product development and delivery, and customer satisfaction assessment, ensuring that enterprises can provide high-quality products and services.ISO9001 sets standards not only for quality management systems but also for overall management systems. It helps various organizations achieve success through improved customer satisfaction, enhanced employee motivation, and continuous improvement.
About AliveX Biotech
AliveX Biotech is a leading AI + multi-omics technology platform company in China, possessing an end-to-end dry and wet lab closed-loop multi-omics experimental platform as well as an AI biocomputing platform. This includes high-quality bioanalytical technologies such as spatiotemporal single-cell omics, targeted proteomics, metabolomics/lipidomics, and computational technologies like multi-omics integrated analysis, AI modeling, knowledge graphs, and disease pharmacological mechanism modeling to efficiently empower R&D. AliveX Biotech has an internationally leading interdisciplinary team of academician professors and industry experts, providing customized scientific research solutions for research institutions and pharmaceutical partners. These include studies on disease and drug mechanisms, discovery and evaluation of biomarkers and targets, patient stratification, multimodal AI prediction, optimization of clinical trial protocols, and precision treatment plans. AliveX Biotech has served over a hundred clinical and research institutes and international large pharmaceutical companies. The company owns dozens of core technology independent intellectual property rights and has obtained national high-tech enterprise certification, CAP certification from the American Society for Clinical Pathology, and ISO9001 certification.
